This presentation will focus on presenting evidence-based information regarding the epidemiology, pathophysiology, diagnosis, assessment, pharmacological management and monitoring of patients with, or at risk for post-transplant osteoporosis. Exposure to this specific population of transplant patients may differ between pharmacists, but it is necessary that all pharmacists understand how to manage this disease state, as a variety of patient populations can be affected by glucocorticoid-induced bone disease. This presentation will incorporate interactive learning questions and case-based application questions to engage pharmacists in an active learning method.